Related Experiment Video
Updated: Mar 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Chemokine RANTES is increased at early stages of coronary artery disease
J Podolec1, G Kopec2, L Niewiara3
1Department of Interventional Cardiology, Jagiellonian University, Collegium Medicum, John Paul II Hospital, Cracow, Poland. jjpodolec@gmail.com.
Insights
Higher levels of chemokine RANTES in peripheral blood were linked to less severe coronary artery disease (CAD). Lower RANTES levels may indicate more diffuse CAD, potentially identifying patients at higher risk for plaque formation.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Cardiovascular diseases, particularly coronary artery disease (CAD), are a leading cause of mortality in Europe.
- Chemokines, such as CCL5/RANTES, play a role in immune cell regulation and vascular processes.
- Identifying reliable markers for cardiovascular risk prediction is crucial.
Purpose of the Study:
- To investigate the association between peripheral blood RANTES levels and the severity of atherosclerosis in patients with stable angina.
- To explore the relationship between RANTES, interleukin-18 (IL-18), and cardiovascular risk factors.
Main Methods:
- Coronary angiography was used to assess atherosclerosis severity in 62 patients.
- RANTES and IL-18 levels were measured using ELISA.
- Flow-mediated dilation (FMD) and intima-media thickness (IMT) were analyzed.
Main Results:
- Mean RANTES levels were significantly higher in patients with lower CAD severity compared to those with severe CAD (P=0.03).
- IL-18 levels and hsCRP concentrations did not differ significantly between groups.
- Flow-mediated dilation (FMD) was significantly lower in patients with severe CAD, indicating endothelial dysfunction.
Conclusions:
- Chemokine RANTES levels may serve as a useful marker for assessing coronary artery disease severity.
- Lower RANTES levels were observed in patients with more diffuse coronary atherosclerosis.
- Elevated RANTES levels in stable angina patients might identify individuals at high risk for early-stage plaque formation.
Abstract:
Cardiovascular diseases, and in particular coronary artery disease (CAD), are the leading causes of death in Europe and represent around 50% of overall mortality. Numerous cardiovascular markers have been proposed in relation to cardiovascular risk prediction, in relation to cardiac and vascular and cerebral events. Chemokines which regulate immune cell vascular chemotaxis, including CCL5/RANTES are points of great interest. We hypothesized that chemokine RANTES level measured in peripheral blood may be associated with severity of atherosclerosis in patients with stable angina undergoing coronary angiography. RANTES and interleukin 18 (IL-18) levels were measured by ELISA. Classical and novel cardiovascular risk factors like brachial flow mediated dilation and intima-media thickness were analyzed in the context of chemokine levels and severity of atherosclerosis. Study included 62 consecutive patients with coronary atherosclerosis demonstrated by coronary angiography, (mean age 59.3 years (S.D. = 7.4)), divided into two groups: group I with lower severity of atherosclerosis, (n = 45) and group 2 with severe CAD (n = 17) based on coronary angiography. Groups were well balanced for classic risk factors for atherosclerosis. Mean RANTES level were significantly higher in patients in group I (67.9 ng/ml, S.E.M. = 3.97) than in group II (50.5 ng/ml, S.E.M. = 7.49; P = 0.03). In contrast, IL-18 levels were similar in both groups (255 pg/ml in group I and 315 pg/ml, S.E.M. = 40.91 in group I, P = 0.12), as well as hsCRP concentration (3.45 S.E.M. = 2.66 ng/ml and 4.69 ng/ml S.E.M.= 1.64 ng/ml respectively; P = 0.47). Flow-mediated dilatation (FMD) values have been significantly lower in group II than in group I (6.31; S.E.M. = 0.61; vs 4.41; S.E.M. = 0,56, respectively, P = 0.026), while nitroglycerine-mediated dilatation (NMD) did not differ, indicating more pronounced endothelial dysfunction. No significant correlations between chemokine RANTES levels and intima-media thickness (IMT), FMD measurements have been found in the total population studied. Chemokine RANTES level could become a useful marker of severity of coronary artery disease. Its lower levels were observed in patients with more diffuse disease. Elevated level of chemokine RANTES in patients with stable angina pectoris may evaluate patients to high risk group in plaque formation at early stages of atherosclerosis.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

